BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23902796)

  • 21. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.
    Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
    PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of DEK protein in hepatocellular carcinoma for progression and prognosis.
    Lin LJ; Chen LT
    Pak J Med Sci; 2013 May; 29(3):778-82. PubMed ID: 24353627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
    Yuan H; Tu SL; He XJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
    Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
    Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periostin expression and its prognostic value for colorectal cancer.
    Li Z; Zhang X; Yang Y; Yang S; Dong Z; Du L; Wang L; Wang C
    Int J Mol Sci; 2015 May; 16(6):12108-18. PubMed ID: 26023718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
    Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
    Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
    Datta A; Adelson ME; Mogilevkin Y; Mordechai E; Sidi AA; Trama JP
    BMC Cancer; 2011 Jun; 11():234. PubMed ID: 21663673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.
    Lin Q; Wei Y; Zhong Y; Zhu D; Ren L; Xu P; Zheng P; Feng Q; Ji M; Lv M; Liang C; Xu J
    Tumour Biol; 2014 Oct; 35(10):9743-50. PubMed ID: 24972972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
    Liu QZ; Gao XH; Chang WJ; Gong HF; Fu CG; Zhang W; Cao GW
    Int J Clin Exp Pathol; 2015; 8(10):12802-10. PubMed ID: 26722470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis.
    Lee CH; Chen SL; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chiou YH; Chen CY; Lin CY; Chen ML; Chen CJ
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
    Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
    Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.